From Our CEO
Bellberry Newsletter – Summer 2025
Welcome to our newsletter for summer 2025. The Bell contains a roundup of the activities Bellberry has been involved with in the last few months, including awarding our Bellberry-Viertel Senior Medical Researcher, CT:IQ activities, Thought Leadership series update, our office relocation and more. If you have any feedback on our newsletter or any suggestions on […]
Read More
From Lab To Life Podcast: Episode 1
Listen to our brand new podcast series, ‘From Lab To Life’, where we go behind the scenes to understand more about the clinical trial and medical research sector. You’ll hear from experts in the sector, including researchers, clinical trial participants and members of Human Research Ethics Committees, exploring challenges and opportunities facing the health and medical […]
Read More
Bellberry Clinical Trial Activity Report 2021
On International Clinical Trials Day, we’re proud to publish the Bellberry Clinical Trial Activity Report 2021. This second annual publication represents a significant proportion of the Australia wide CTN trial activity across the development lifecycle. It demonstrates capability and capacity in a broad range of research areas. The report also captures the originating funding location […]
Read More
Launch of Exciting New Australian Clinical Trials Initiative, CT:IQ!
We are delighted to announce that Bellberry, ACTA, NHMRC CTC and The George Institute have formed a consortium ‘Clinical Trials: Impact & Quality (CT:IQ)’. The consortium’s mission is “to develop and implement recommendations that will improve the impact, quality and efficiency of clinical trials, leading to more rapid, lower cost and higher quality evaluation of […]
Read More